XML 74 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statement of Operations (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2010
Sep. 30, 2010
Jun. 30, 2010
Mar. 31, 2010
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Consolidated Statement of Operations [Abstract]                      
Revenues $ 12,101.4 $ 11,571.0 $ 11,361.4 $ 11,094.5 $ 11,294.2 $ 11,251.8 $ 11,288.8 $ 11,138.4 $ 46,128.3 [1] $ 44,973.2 [1] $ 24,722.3 [1]
Cost of revenues 11,256.9 10,735.2 10,577.3 10,349.0 10,520.8 10,487.7 10,531.3 10,475.2 42,918.4 [1] 42,015.0 [1] 22,298.3 [1]
Gross profit 844.5 835.8 784.1 745.5 773.4 764.1 757.5 663.2 3,209.9 2,958.2 2,424.0
Selling, general and administrative 269.6 230.7 204.8 193.1 215.5 236.1 227.2 208.5 898.2 887.3 926.5
Operating income 574.9 605.1 579.3 552.4 557.9 528.0 530.3 454.7 2,311.7 2,070.9 1,497.5
Other (expense) income:                      
Interest income                 12.4 4.9 5.3
Interest expense and other                 (299.7) (167.1) (194.4)
Total other (expense) income                 (287.3) (162.2) (189.1)
Income before income taxes                 2,024.4 1,908.7 1,308.4
Provision for income taxes                 748.6 704.1 481.8
Net income from continuing operations         329.6 307.1 307.3 260.6 1,275.8 1,204.6 826.6
Net (loss) income from discontinued operations, net of tax           (5.6) (17.4) (0.4) 0 (23.4) 1.0
Net income $ 290.4 $ 324.7 $ 334.2 $ 326.5 $ 329.6 $ 301.5 $ 289.9 $ 260.2 $ 1,275.8 $ 1,181.2 $ 827.6
Weighted average number of common shares outstanding during the period:                      
Basic:                 500.9 538.5 527.0
Diluted:                 505.0 544.0 532.2
Basic earnings (loss) per share:                      
Continuing operations         $ 0.62 $ 0.58 $ 0.56 $ 0.47 $ 2.55 $ 2.24 $ 1.57
Discontinued operations           $ (0.01) $ (0.03)     $ (0.04)  
Net earnings $ 0.60 $ 0.67 $ 0.66 $ 0.62 $ 0.62 $ 0.57 $ 0.53 $ 0.47 $ 2.55 $ 2.19 $ 1.57
Diluted earnings (loss) per share:                      
Continuing operations         $ 0.62 $ 0.57 $ 0.56 $ 0.47 $ 2.53 $ 2.21 $ 1.55
Discontinued operations           $ (0.01) $ (0.03)     $ (0.04)  
Net earnings $ 0.59 $ 0.66 $ 0.66 $ 0.61 $ 0.62 $ 0.56 $ 0.53 $ 0.47 $ 2.53 $ 2.17 $ 1.56
[1] Includes retail pharmacy co-payments of $5786.6, $6,181.4, and $3,132.1, for the years ended December 31, 2011, 2010, and 2009, respectively.